Many Nasal Polyp Patients Stopped Dupilumab in Small Study
Almost one quarter of patients who were taking dupilumab for nasal polyposis stopped taking the drug because of adverse events.
Source: medscape.com
Stay updated with breaking news from More Extensive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Almost one quarter of patients who were taking dupilumab for nasal polyposis stopped taking the drug because of adverse events.